Abstract:The cellular prion protein (PrPC) is a highly conserved glycosylphosphatidylinositol (GPI)-anchored membrane protein that is involved in the signal transduction during the initial phase of neurite outgrowth. The Ras homolog gene family member A (RhoA) is a small GTPase that is known to have an essential role in regulating the development, differentiation, survival, and death of neurons in the central nervous system. Although recent studies have shown the dysregulation of RhoA in a variety of neurodegenerative diseases, the role of RhoA in prion pathogenesis remains unclear. Here, we investigated the regulation of RhoA-mediated signaling by PrPC using both in vitro and in vivo models and found that overexpression of PrPC significantly induced RhoA inactivation and RhoA phosphorylation in hippocampal neuronal cells and in the brains of transgenic mice. Using siRNA-mediated depletion of endogenous PrPC and overexpression of disease-associated mutants of PrPC, we confirmed that PrPC induced RhoA inactivation, which accompanied RhoA phosphorylation but reduced the phosphorylation levels of LIM kinase (LIMK), leading to cofilin activation. In addition, PrPC colocalized with RhoA, and the overexpression of PrPC significantly increased neurite outgrowth in nerve growth factor-treated PC12 cells through RhoA inactivation. However, the disease-associated mutants of PrPC decreased neurite outgrowth compared with wild-type PrPC. Moreover, inhibition of Rho-associated kinase (ROCK) substantially facilitated neurite outgrowth in NGF-treated PC12 cells, similar to the effect induced by PrPC. Interestingly, we found that the induction of RhoA inactivation occurred through the interaction of PrPC with RhoA and that PrPC enhanced the interaction between RhoA and p190RhoGAP (a GTPase-activating protein). These findings suggest that the interactions of PrPC with RhoA and p190RhoGAP contribute to neurite outgrowth by controlling RhoA inactivation and RhoA-mediated signaling and that disease-associated mutations of PrPC impair RhoA inactivation, which in turn leads to prion-related neurodegeneration.

RhoA Signaling in Neurodegenerative Diseases

RhoA Signaling in Neurodegenerative Diseases

Signaling Pathways Regulating Neuron–glia Interaction and Their Implications in Alzheimer's Disease

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Ras, RhoA, and vascular pharmacology in neurodevelopment and aging

Small GTPases of the Ras and Rho Families Switch on/off Signaling Pathways in Neurodegenerative Diseases

Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets

RhoA as a Key Regulator of Innate and Adaptive Immunity

Rho/ROCK and Neurological Diseases

Regulation of RhoA activity by the cellular prion protein

Neuregulins in Neurodegenerative Diseases

Rho signaling pathway targeted to promote spinal cord repair

The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases.

The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia

RhoA as a target to promote neuronal survival and axon regeneration

ROCK inhibition in models of neurodegeneration and its potential for clinical translation

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis

Signaling Through Rho GTPase Pathway As Viable Drug Target.

Untangling the role of RhoA in the heart: protective effect and mechanism

Interactions between Ras and Rap signaling pathways during neurodevelopment in health and disease